| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | -37.4% |
| SG&A Expense | $5.7M | -22.1% |
| Operating Income | -$25.5M | -179.0% |
| Pre-tax Income | -$25.8M | -174.3% |
| Income Tax | -$852K | — |
| Net Income | -$25.0M | -165.1% |
| EPS (Basic) | -$4.18 | +50.7% |
| EPS (Diluted) | -$4.18 | +50.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $348K | -79.7% |
| Total Assets | $348K | -98.3% |
| Current Liabilities | $12.7M | +13.4% |
| Total Liabilities | $12.7M | +5.4% |
| Stockholders' Equity | -$12.4M | -245.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | +32.3% |
| Financing Cash Flow | $3.7M | -38.1% |